Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma
Completed · Not applicable
Conditions studied: Subdural Hematoma
In brief
The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the Onyx™ Liquid Embolic System (LES) for treatment of symptomatic subacute or chronic subdural hematoma (SDH)
Key facts
- Study ID
- NCT04402632
- Run by
- Medtronic Neurovascular Clinical Affairs
- People needed
- 600
- Starts
- 2020-10-27
- Expected to finish
- 2025-04-03
- Last updated by the study team
- 2025-12-11
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Pre-morbid Modified Rankin Score ≤3
- Confirmed diagnosis of subacute or chronic subdural hematoma
- Completed informed consent
- Meets criteria for Surgery or Observation Cohort
You may not qualify if…
- Life expectancy <1 year
- Unable to complete follow-up
- Pregnant, lactating, or has a positive pregnancy test at time of admission
- Diagnosed with acute SDH
- Potentially dangerous anatomic variations leading to increased procedural risk or unsafe access for MMA embolization
- Pre-randomized Markwalder Grading Scale score ≥ 3
- Unmanaged, uncontrolled bleeding disorders/blood diathesis
- Presumed septic embolus, or suspicion of microbial superinfection
- Known active COVID-19 infection
- CT or MRI evidence of intra-cranial tumor or mass lesion Contraindication to angiography
- Participation in another clinical trial
- Contraindicated for the use of Onyx™ LES
- Cannot be taken off corticosteroids (intended to treat subacute or chronic SDH) for at least 90 days post-randomization
Where it is running
- University of Alabama at Birmingham (UAB) Hospital — Birmingham, Alabama, United States
- Carondelet St. Joseph's Hospital — Tucson, Arizona, United States
- University of California Irvine Medical Center — Irvine, California, United States
- USC - Keck School of Medicine — Los Angeles, California, United States
- Huntington Memorial Hospital — Pasadena, California, United States
- UCSD Medical Center — San Diego, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- University of California San Francisco Medical Center — San Francisco, California, United States
- Providence Little Company of Mary Medical Center — Torrance, California, United States
- University of Colorado Denver School of Medicine — Aurora, Colorado, United States
- UF Health Heart and Vascular Hospital — Gainesville, Florida, United States
- Memorial Regional Hospital — Hollywood, Florida, United States
- Baptist Medical Center Jacksonville — Jacksonville, Florida, United States
- Jackson Memorial Hospital — Miami, Florida, United States
- Orlando Regional Medical Center Orlando Health — Orlando, Florida, United States
- Tampa General Hospital — Tampa, Florida, United States
- Saint Mary's Medical Center — West Palm Beach, Florida, United States
- Grady Memorial Hospital — Atlanta, Georgia, United States
- Rush University Medical Center — Chicago, Illinois, United States
- Advocate Lutheran General Hospital — Park Ridge, Illinois, United States
- Ascension Saint Vincent Hospital — Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- University of Kentucky Albert B Chandler Hospital — Lexington, Kentucky, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Lahey Hospital & Medical Center — Burlington, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.